Will This EMS Inventory Obtain $11 Billion in Income by FY28? This is What Analysts Say

Synopsis:
A number one EMS participant posted stellar Q1 development with doubled income and sturdy cellular phase efficiency. Backward integration, JVs, and exports gasoline enlargement, whereas world brokerage sees 26% upside, projecting $11 billion income by FY28, guaranteeing scalability past PLI help.

India’s client electronics sector was valued at about USD 84 billion in 2024 and is projected to succeed in over USD 150 billion by 2033, rising at a CAGR of almost 7%. Pushed by rising incomes, urbanization, and web penetration, now over 950 million customers, the trade is adopting sensible and linked units backed by robust authorities insurance policies and native manufacturing.

With a market capitalization of Rs 1,07,928.24 crore, the shares of Dixon Applied sciences (India) Ltd had been at Rs 17,835.35 per share, lowering round 2 % as in comparison with the earlier closing of Rs 18,192.55 apiece.

UBS, one of many well-known brokerages globally, has upgraded to a ‘Purchase’ score & raised its goal value on this EMS inventory to Rs 23,000 per share, indicating a possible upside of 29 % from Friday’s value of Rs 17,835.35 per share.

Dixon is strategically increasing into non-semiconductor smartphone elements, together with shows, digicam modules, enclosures, and batteries, marking its subsequent development part. 

In response to UBS, this backward integration may considerably improve operational effectivity, probably boosting EBITDA margins by 110 foundation factors by FY28E, effectively above expectations of 40 foundation factors. The enlargement is designed to offset the anticipated phase-out of the cellular PLI scheme by FY26, positioning Dixon for stronger profitability and a extra diversified product portfolio within the evolving electronics manufacturing ecosystem.

UBS highlights Dixon’s inorganic enlargement by way of a number of JVs and acquisitions, reflecting its technique to unlock development by broadening TAM, reaching vertical integration, getting into new product classes, and strengthening world partnerships, positioning the corporate for sustained long-term scalability.

Additionally learn: Tata Motors and 4 different auto shares in focus after Trump imposes 25% tariffs on heavy-duty vans

Dixon is projected to attain $11 billion in income by FY28E, 2.5× FY25 estimates. Development drivers embody increasing element gross sales past captive use, boosting exports, getting into new verticals like networking and servers, and exploring potential inorganic alternatives.

The corporate delivered robust development in Q1FY26, with income surging 95% to  Rs 12,836 crore from  Rs 6,580 crore a yr in the past. Web revenue additionally doubled to  Rs 280 crore from  Rs 140 crore, reflecting operational effectivity and improved demand momentum, showcasing sturdy enterprise fundamentals and monetary energy.

Dixon’s cellular phase delivered stellar development in Q1FY26, with income up 125 % YoY to Rs 11,663 crore and working revenue rising 131 % to Rs 395 crore. In Q2, demand for smartphones seems to be even stronger, with sturdy order visibility, and festive season tailwinds help momentum. Strategic JVs, backward integration, and enlargement in Noida additional strengthen its management, enhancing scale, profitability, and long-term competitiveness.

Dixon sees large export development, focusing on  Rs 7,000 crore in FY26 in opposition to  Rs 1,600 crore final yr, with potential to scale to  Rs 11,000–12,000 crore. Exports to Africa have begun, with massive anchor alternatives forward. Administration stays assured of sustaining development past PLI, leveraging robust buyer relationships, JVs, and backward integration to offset incentive losses successfully.

Written by Abhishek Singh

Disclaimer

The views and funding suggestions expressed by funding consultants/broking homes/score companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of monetary losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Non-public Restricted or the writer should not chargeable for any losses induced on account of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.